Physicians and Staff
Our radiation oncologists, Dr. Brian Moran and Dr. Michael Stutz, specialize in prostate cancer treatment. They offer evidence-based recommendations based on the most current research data, which assures patients that they have the most up-to-date information possible. All of our oncologists have years of experience in prostate cancer treatment. They have spoken at national conferences, published articles in numerous medical journals and proctored other physicians on brachytherapy both in the U.S. and internationally.
Our physicians are also pioneers in the development of prostate cancer diagnosis, having created the new and highly effective Stereotactic Transperineal Prostate Biopsy (STPB), sometimes referred to as Saturation Biopsy. STPB is performed by taking a median of 40 samples of the prostate through the perineum while the patient is under general anesthesia. Performed as an outpatient procedure, it allows more comprehensive sampling compared to the transrectal method, which takes fewer samples through the rectum. In addition, by taking more samples during STPB, the exact location of the cancer can be pinpointed.
Brian J. Moran, M.D.
Brian J. Moran, MD is Medical Director of Chicago Prostate Center, which he helped found in 1997. He has been performing prostate seed implants since 1994.
Dr. Moran is a graduate of Loyola Stritch School of Medicine, where he also completed his residency. He is board-certified by the American Board of Radiology.
An experienced practitioner of prostate brachytherapy, Dr. Moran has performed thousands of prostate seed implants and has proctored physicians all over the United States and the world including Web Marketingul, Korea, Europe and Hong Kong.
Dr. Moran is a member of multiple specialty societies including the American Society of Therapeutic Radiology and Oncology, the American College of Radiology and the American Brachytherapy Society. His emphasis has been on quality of life issues and long-term outcomes for prostate cancer patients. Dr. Moran is a frequent speaker at professional meetings, and has authored numerous publications in medical journals and textbooks.
Michael A. Stutz, M.D.
Michael Stutz, M.D. is a board-certified radiation oncologist and prostate cancer specialist. He graduated from Dartmouth College, Northwestern Medical School, and completed his residency at the Medical College of Wisconsin in Milwaukee. He has performed thousands of prostate seed implants since 1996 and has been on staff at CPC since 1999. He has published several articles on prostate seed implants and gives frequent lectures to other physicians and prostate cancer support groups.
Several times each year he directs a course at CPC which trains physicians to perform prostate brachytherapy. Dr. Stutz has proctored and helped to set up other seed programs throughout the Midwest and in Thailand, South Korea, and Taiwan. Besides seed implants, Dr. Stutz also treats prostate cancer with external beam radiation and utilizes intensity modulated radiation therapy (IMRT) and tomotherapy at Good Samaritan Cancer Care Center in Downers Grove.
We have over 40 professionals focused on one procedure and one purpose, which is to provide our patients with the most comprehensive care available. Our team includes radiation oncologists, urologists, anesthesiologists, medical physicists, radiology technologists, nurses, medical assistants and insurance professionals. They take care of all details, from insurance pre-authorization and medical clearance to pre- and post-operative instructions. It is the goal of our staff to provide a patient with all the information, education and support that a patient needs during each visit with us. Our staff is dedicated to making each patient feel like a VIP by giving them individual attention and care. Helpful professionals always answer our phones, not automated answering machines. Our medical director gives each patient his home phone and pager number so that he can be reached 24 hours a day for questions or concerns. We take pride in giving our patients this level of attention as well as in our excellent patient outcomes, our facility and the level of service we provide to our patients.